Status and phase
Conditions
Treatments
About
Full description
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Male and female subjects aged from 18 to 65 years old (including 18 and 65 years old), the ratio of male to female was 1:1;
Body weight: male ≥50.0kg, female ≥45.0kg, body mass index [BMI= weight (kg)/height 2 (m2)] between 19.0 kg/m2 and 26.0kg/m2 (including boundary values);
90mmHg≤ systolic blood pressure <140mmHg, 60mmHg≤ diastolic blood pressure <90 mmHg, 60 beats/min ≤ pulse ≤100 beats/min, normal body temperature (abnormal vital signs could be retested, normal retest results were considered to meet the inclusion criteria);
The results of ECG were normal or abnormal but not clinically significant, including QTcF≤450 ms in men and QTcF≤470 ms in women, PR interval
Before the trial, they have understood the nature, significance, possible benefits, possible inconvenience and potential risks of the trial in detail, and voluntarily participate in the clinical trial, can communicate well with the investigators, comply with the requirements of the whole study, and sign the written informed consent.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
20 participants in 1 patient group
Loading...
Central trial contact
Yuanyuan Chu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal